This report studies Gastroesophageal Reflux Disease Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
AstraZeneca
Eisai
Takeda Pharmaceutical
GlaxoSmithKline
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
Rottapharm Madaus
Peer Medical
Reviva Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Antacids
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Pro-kinetic Agents
Others
By Application, the market can be split into
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Gastroesophageal Reflux Disease Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Gastroesophageal Reflux Disease Therapeutics
1.1 Definition and Specifications of Gastroesophageal Reflux Disease Therapeutics
1.1.1 Definition of Gastroesophageal Reflux Disease Therapeutics
1.1.2 Specifications of Gastroesophageal Reflux Disease Therapeutics
1.2 Classification of Gastroesophageal Reflux Disease Therapeutics
1.2.1 Antacids
1.2.2 H2 Receptor Blockers
1.2.3 Proton Pump Inhibitors (PPIs)
1.2.4 Pro-kinetic Agents
1.2.5 Others
1.3 Applications of Gastroesophageal Reflux Disease Therapeutics
1.3.1 Hospital Pharmacy
1.3.2 Drug Stores
1.3.3 General Stores
1.3.4 Supermarkets
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Gastroesophageal Reflux Disease Therapeutics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gastroesophageal Reflux Disease Therapeutics
2.3 Manufacturing Process Analysis of Gastroesophageal Reflux Disease Therapeutics
2.4 Industry Chain Structure of Gastroesophageal Reflux Disease Therapeutics
3 Technical Data and Manufacturing Plants Analysis of Gastroesophageal Reflux Disease Therapeutics
3.1 Capacity and Commercial Production Date of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
4 Global Gastroesophageal Reflux Disease Therapeutics Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Gastroesophageal Reflux Disease Therapeutics Capacity and Growth Rate Analysis
4.2.2 2016 Gastroesophageal Reflux Disease Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Gastroesophageal Reflux Disease Therapeutics Sales and Growth Rate Analysis
4.3.2 2016 Gastroesophageal Reflux Disease Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Gastroesophageal Reflux Disease Therapeutics Sales Price
4.4.2 2016 Gastroesophageal Reflux Disease Therapeutics Sales Price Analysis (Company Segment)
5 Gastroesophageal Reflux Disease Therapeutics Regional Market Analysis
5.1 North America Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.1.1 North America Gastroesophageal Reflux Disease Therapeutics Market Overview
5.1.2 North America 2012-2017E Gastroesophageal Reflux Disease Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price Analysis
5.1.4 North America 2016 Gastroesophageal Reflux Disease Therapeutics Market Share Analysis
5.2 China Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.2.1 China Gastroesophageal Reflux Disease Therapeutics Market Overview
5.2.2 China 2012-2017E Gastroesophageal Reflux Disease Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price Analysis
5.2.4 China 2016 Gastroesophageal Reflux Disease Therapeutics Market Share Analysis
5.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.3.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Overview
5.3.2 Europe 2012-2017E Gastroesophageal Reflux Disease Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price Analysis
5.3.4 Europe 2016 Gastroesophageal Reflux Disease Therapeutics Market Share Analysis
5.4 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.4.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Overview
5.4.2 Southeast Asia 2012-2017E Gastroesophageal Reflux Disease Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price Analysis
5.4.4 Southeast Asia 2016 Gastroesophageal Reflux Disease Therapeutics Market Share Analysis
5.5 Japan Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.5.1 Japan Gastroesophageal Reflux Disease Therapeutics Market Overview
5.5.2 Japan 2012-2017E Gastroesophageal Reflux Disease Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price Analysis
5.5.4 Japan 2016 Gastroesophageal Reflux Disease Therapeutics Market Share Analysis
5.6 India Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.6.1 India Gastroesophageal Reflux Disease Therapeutics Market Overview
5.6.2 India 2012-2017E Gastroesophageal Reflux Disease Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price Analysis
5.6.4 India 2016 Gastroesophageal Reflux Disease Therapeutics Market Share Analysis
6 Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Segment Market Analysis (by Type)
6.1 Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales by Type
6.2 Different Types of Gastroesophageal Reflux Disease Therapeutics Product Interview Price Analysis
6.3 Different Types of Gastroesophageal Reflux Disease Therapeutics Product Driving Factors Analysis
6.3.1 Antacids of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
6.3.2 H2 Receptor Blockers of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
6.3.3 Proton Pump Inhibitors (PPIs) of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
6.3.4 Pro-kinetic Agents of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
6.3.5 Others of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
7 Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Segment Market Analysis (by Application)
7.1 Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Consumption by Application
7.2 Different Application of Gastroesophageal Reflux Disease Therapeutics Product Interview Price Analysis
7.3 Different Application of Gastroesophageal Reflux Disease Therapeutics Product Driving Factors Analysis
7.3.1 Hospital Pharmacy of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
7.3.2 Drug Stores of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
7.3.3 General Stores of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
7.3.4 Supermarkets of Gastroesophageal Reflux Disease Therapeutics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Gastroesophageal Reflux Disease Therapeutics
8.1 AstraZeneca
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 AstraZeneca 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 AstraZeneca 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.2 Eisai
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Eisai 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eisai 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.3 Takeda Pharmaceutical
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Takeda Pharmaceutical 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Takeda Pharmaceutical 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.4 GlaxoSmithKline
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 GlaxoSmithKline 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 GlaxoSmithKline 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.5 Johnson & Johnson
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Johnson & Johnson 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Johnson & Johnson 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.6 Daewoong Pharmaceutical
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Daewoong Pharmaceutical 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Daewoong Pharmaceutical 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.7 Ironwood Pharmaceuticals
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Ironwood Pharmaceuticals 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Ironwood Pharmaceuticals 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.8 Rottapharm Madaus
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Rottapharm Madaus 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Rottapharm Madaus 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.9 Peer Medical
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Peer Medical 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Peer Medical 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
8.10 Reviva Pharmaceuticals
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Reviva Pharmaceuticals 2016 Gastroesophageal Reflux Disease Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Reviva Pharmaceuticals 2016 Gastroesophageal Reflux Disease Therapeutics Business Region Distribution Analysis
9 Development Trend of Analysis of Gastroesophageal Reflux Disease Therapeutics Market
9.1 Global Gastroesophageal Reflux Disease Therapeutics Market Trend Analysis
9.1.1 Global 2017-2022 Gastroesophageal Reflux Disease Therapeutics Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Gastroesophageal Reflux Disease Therapeutics Sales Price Forecast
9.2 Gastroesophageal Reflux Disease Therapeutics Regional Market Trend
9.2.1 North America 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Forecast
9.2.2 China 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Forecast
9.2.3 Europe 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Forecast
9.2.5 Japan 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Forecast
9.2.6 India 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Forecast
9.3 Gastroesophageal Reflux Disease Therapeutics Market Trend (Product Type)
9.4 Gastroesophageal Reflux Disease Therapeutics Market Trend (Application)
10 Gastroesophageal Reflux Disease Therapeutics Marketing Type Analysis
10.1 Gastroesophageal Reflux Disease Therapeutics Regional Marketing Type Analysis
10.2 Gastroesophageal Reflux Disease Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Gastroesophageal Reflux Disease Therapeutics by Region
10.4 Gastroesophageal Reflux Disease Therapeutics Supply Chain Analysis
11 Consumers Analysis of Gastroesophageal Reflux Disease Therapeutics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Gastroesophageal Reflux Disease Therapeutics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Gastroesophageal Reflux Disease Therapeutics
Table Product Specifications of Gastroesophageal Reflux Disease Therapeutics
Table Classification of Gastroesophageal Reflux Disease Therapeutics
Figure Global Production Market Share of Gastroesophageal Reflux Disease Therapeutics by Type in 2016
Figure Antacids Picture
Table Major Manufacturers of Antacids
Figure H2 Receptor Blockers Picture
Table Major Manufacturers of H2 Receptor Blockers
Figure Proton Pump Inhibitors (PPIs) Picture
Table Major Manufacturers of Proton Pump Inhibitors (PPIs)
Figure Pro-kinetic Agents Picture
Table Major Manufacturers of Pro-kinetic Agents
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Gastroesophageal Reflux Disease Therapeutics
Figure Global Consumption Volume Market Share of Gastroesophageal Reflux Disease Therapeutics by Application in 2016
Figure Hospital Pharmacy Examples
Table Major Consumers in Hospital Pharmacy
Figure Drug Stores Examples
Table Major Consumers in Drug Stores
Figure General Stores Examples
Table Major Consumers in General Stores
Figure Supermarkets Examples
Table Major Consumers in Supermarkets
Figure Market Share of Gastroesophageal Reflux Disease Therapeutics by Regions
Figure North America Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2012-2022)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2012-2022)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2012-2022)
Table Gastroesophageal Reflux Disease Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gastroesophageal Reflux Disease Therapeutics in 2016
Figure Manufacturing Process Analysis of Gastroesophageal Reflux Disease Therapeutics
Figure Industry Chain Structure of Gastroesophageal Reflux Disease Therapeutics
Table Capacity and Commercial Production Date of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Gastroesophageal Reflux Disease Therapeutics 2012-2017
Figure Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Gastroesophageal Reflux Disease Therapeutics Capacity and Growth Rate
Table 2016 Global Gastroesophageal Reflux Disease Therapeutics Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) and Growth Rate
Table 2016 Global Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs)
Table 2016 Global Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Gastroesophageal Reflux Disease Therapeutics 2012-2017E
Figure North America 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs)
Figure North America 2016 Gastroesophageal Reflux Disease Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Gastroesophageal Reflux Disease Therapeutics 2012-2017E
Figure China 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs)
Figure China 2016 Gastroesophageal Reflux Disease Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Gastroesophageal Reflux Disease Therapeutics 2012-2017E
Figure Europe 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs)
Figure Europe 2016 Gastroesophageal Reflux Disease Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Gastroesophageal Reflux Disease Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Gastroesophageal Reflux Disease Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Gastroesophageal Reflux Disease Therapeutics 2012-2017E
Figure Japan 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs)
Figure Japan 2016 Gastroesophageal Reflux Disease Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Gastroesophageal Reflux Disease Therapeutics 2012-2017E
Figure India 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs)
Figure India 2016 Gastroesophageal Reflux Disease Therapeutics Sales Market Share
Table Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) by Type
Table Different Types Gastroesophageal Reflux Disease Therapeutics Product Interview Price
Table Global 2012-2017E Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) by Application
Table Different Application Gastroesophageal Reflux Disease Therapeutics Product Interview Price
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Eisai Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eisai Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Eisai Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Takeda Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2015 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Daewoong Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Ironwood Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Rottapharm Madaus Information List
Table Product A Overview
Table Product B Overview
Table 2016 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Peer Medical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Peer Medical Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Peer Medical Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Table Reviva Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Region Distribution
Figure Global 2017-2022 Gastroesophageal Reflux Disease Therapeutics Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Gastroesophageal Reflux Disease Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Gastroesophageal Reflux Disease Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Gastroesophageal Reflux Disease Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Gastroesophageal Reflux Disease Therapeutics by Region
